< WE ARE > A Boutique consulting firm that provides an array of management consulting and technology implementation services, providing entrepreneurs, or decision makers with expert guidance in key decision areas ranging from go-to-market to international development. Our seniority is bringing value to our clients based on the first-hand experience of our subject-matter expert consultants. < WE MAKE THE DIFFERENCE > We provide expert advice on Market and Managerial Trends as well as successful applications, we provide Expertise by seniority as well as Insight, but we double down on Execution. < OUR SERVICES IN THE LIFE SCIENCE INDUSTRY > Discover what Bespoke Biotech Advisory can do for your business and how. Yes, We provide expert advice on Market and Managerial Trends as well as successful applications, we provide Expertise by seniority as well as Insight, but we double down on Execution. < WHAT > - Strategy (Setting and Execution) - Go to Market - Marketing & Sales - Business Development (Partnerships, Licensings, Lead Generation, Sales Channels) - M&A, Fund Raising - Technology Scouting - Digital Transformation and Integration aligned to Company Strategy (Study,Plan,Do) - Organization and Change; Temporary INSIDE engagements < TO WHO > 🧪 Segments: - Biotechnological products and ancillary services - Digital Health and Precision Medicine - Diagnostics and Medical Devices - Nutraceuticals and Cosmeceutics - Vaccines and infectious diseases 🔬 Entrepreneurs: SME’s with expansion and enhancement goals, Start Ups -Scale Ups or projects at stage TRL 6/7 or microbusiness from stage CM 4/5 👨💼 Investors: with or without specific knowledge of industry and segments < HOW > - Achieve consistent long term growth - Make key decisions - Develop digital strategies that deliver - Leverage the power of our tools and techniques to ensure execution of strategy 💡 Through a network of specialized it companies we also provide expert advice on digital transformation.
Link esterno per BBA Srl - Bespoke Biotech Advisory
Strada Petriccio e Belriguardo, 35
c/o Toscana Life Sciences
Siena, Toscana 53100, IT
BBA Srl - Bespoke Biotech Advisory ha diffuso questo post
Our focus on Ikonisys S.A. (Euronext Growth Paris: ALIKO.PA) a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis laboratories. Be ready for the upcoming Group's steps to become a global leader in next-generation cancer diagnostics https://lnkd.in/dK8qjxhe
BBA Srl - Bespoke Biotech Advisory ha diffuso questo post
Ulisse Biomed Spa (Euronext Growth Milan_ reuters Ticker :UBM) an Italian biotech company, active in molecular diagnostics solutions as well as engaged in creating novel, innovative and transformative diagnostic platforms and products (i.e.: its HPV tests confirmed among the bestpractices worldwide) , late in december 2024 announced that it has completed the capital increase with the issue of 1,700,000 ordinary shares, for a total of 1.31 million euros. The newly issued shares are offered for subscription and are issued with the exclusion of the option right, as they are to be reserved for HI Algebris SME innovative Eltif, a fund managed by Algebris. As a result of the commitments undertaken, Algebris has subscribed to all the shares. for more info : https://lnkd.in/dzSK9Cwz
BBA Srl - Bespoke Biotech Advisory ha diffuso questo post
Ikonisys SA (Euronext Growth Paris: ALIKO.PA), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, on dec 31,2024 announced that it has completed the acquisition of Hospitex International Srl, with the issuance of 2 million new Ikonisys shares to ETH Scientific Srl, the former owner of Hospitex. Visit: alikoscientific.com https://lnkd.in/dcVDfpg9
Ulisse Biomed Spa (Euronext Growth Milan_ reuters Ticker :UBM) an Italian biotech company, active in molecular diagnostics solutions as well as engaged in creating novel, innovative and transformative diagnostic platforms and products (i.e.: its HPV tests confirmed among the bestpractices worldwide) , late in december 2024 announced that it has completed the capital increase with the issue of 1,700,000 ordinary shares, for a total of 1.31 million euros. The newly issued shares are offered for subscription and are issued with the exclusion of the option right, as they are to be reserved for HI Algebris SME innovative Eltif, a fund managed by Algebris. As a result of the commitments undertaken, Algebris has subscribed to all the shares. for more info : https://lnkd.in/dzSK9Cwz
Ikonisys SA (Euronext Growth Paris: ALIKO.PA), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, on dec 31,2024 announced that it has completed the acquisition of Hospitex International Srl, with the issuance of 2 million new Ikonisys shares to ETH Scientific Srl, the former owner of Hospitex. Visit: alikoscientific.com https://lnkd.in/dcVDfpg9
Our focus on Ikonisys S.A. (Euronext Growth Paris: ALIKO.PA) a company specializing in the early and accurate detection of cancers through a unique fully automated solution for medical analysis laboratories. Be ready for the upcoming Group's steps to become a global leader in next-generation cancer diagnostics https://lnkd.in/dK8qjxhe